Table 4 Extraction Tool

IDENTIFICATION

1. In what country did the implementation take place?

2. What level or part of the system did the priority setting implementation take place? (e.g., national, provincial, regional, hospital, community care, etc.)

3. What was the scope or context of the implementation? (e.g., drugs, vaccines, disease area, across disease areas, across sectors, etc.)

DECISION-MAKING

4. Who establishes the strategic guidance for the organization and how specific is it (i.e. how much room is there for interpretation)?

5. How does the organization establish priorities and make decisions on where to increase or reduce spending?

• Is there any formal process or framework that is used for that purpose or is it done on a case by case basis?

• How are requests for funding initiated? Who do they go to?

• Is current spending typically reviewed as part of the process?

• Are the organization’s priority setting decisions subject to review by external stakeholder(s)?

6. What stakeholders were involved in the decision-making process? (e.g., researchers, policy makers, public members, patients, clinicians)

7. What types of evidence/information are taken into account? (e.g., epidemiological evidence, clinical evidence, economic evidence, expert opinion, patient reported outcomes)

EVALUATION

8. Was there a reported discrepancy between ‘recommendations’ and actions taken?

9. Was the implementation formally evaluated and if so what were the findings of the evaluation (specifically, were health outcomes impact assessed)? How successful was the implementation? What are the key lessons learned?

10. What was the level of political involvement? Were notions of equity explicitly considered?